SCRI Denver Drug Development Unit — Denver, Colorado

SCRI Denver Drug Development Unit is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI Denver Drug Development Unit has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Locally Advanced Solid Tumor, Metastatic Solid Tumor.

Sponsors: Acepodia Biotech, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Denver Drug Development Unit?

SCRI Denver Drug Development Unit has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Denver Drug Development Unit conducted?

SCRI Denver Drug Development Unit has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced Solid Tumor, Metastatic Solid Tumor.

Is SCRI Denver Drug Development Unit accredited by Crixeo Health?

SCRI Denver Drug Development Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Denver Drug Development Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.